PT2628746T - Um processo para a concentração de um polipéptido - Google Patents

Um processo para a concentração de um polipéptido

Info

Publication number: PT2628746T
Authority: PT; Portugal
Prior art keywords: polypeptide; concentration
Prior art date: 2006-04-04

Application number

PT13167427T

Other languages

English (en)

Inventor

Nilsson Stefan

Original Assignee

Chiesi Farm Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-04

Filing date

2007-04-04

Publication date

2019-04-23

2007-04-04 Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa

2019-04-23 Publication of PT2628746T publication Critical patent/PT2628746T/pt

Links

229920001184 polypeptide Polymers 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01061—Hydroxymethylbilane synthase (2.5.1.61)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06001—Arylsulfatase (3.1.6.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01024—Alpha-mannosidase (3.2.1.24)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01046—Galactosylceramidase (3.2.1.46)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06008—Cerebroside-sulfatase (3.1.6.8)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Water Supply & Treatment (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Hematology (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PT13167427T 2006-04-04 2007-04-04 Um processo para a concentração de um polipéptido PT2628746T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200600488		2006-04-04
DKPA200600922		2006-07-05

Publications (1)

Publication Number	Publication Date
PT2628746T true PT2628746T (pt)	2019-04-23

Family

ID=38472949

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT13167427T PT2628746T (pt)	2006-04-04	2007-04-04	Um processo para a concentração de um polipéptido

Country Status (20)

Country	Link
US (6)	US20090246187A1 (pt)
EP (4)	EP2631242B1 (pt)
JP (6)	JP2009532394A (pt)
KR (3)	KR20140057678A (pt)
CN (1)	CN105233276A (pt)
AU (2)	AU2007234195B2 (pt)
BR (1)	BRPI0709737A2 (pt)
CA (3)	CA2644642C (pt)
DK (1)	DK2628746T3 (pt)
ES (3)	ES2713488T3 (pt)
HU (1)	HUE042402T2 (pt)
IL (4)	IL194267A (pt)
MX (1)	MX2008012748A (pt)
NO (3)	NO347673B1 (pt)
NZ (7)	NZ588903A (pt)
PL (3)	PL2100898T3 (pt)
PT (1)	PT2628746T (pt)
SI (1)	SI2628746T1 (pt)
WO (1)	WO2007112757A2 (pt)
ZA (2)	ZA200805346B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4586027B2 (ja)	2004-01-30	2010-11-24	シャイアファーマシューティカルズアイルランドリミテッド	組換えアリールスルファターゼａの製造及び精製
MX2008012748A (es)	2006-04-04	2009-01-07	Shire Pharmaceuticals Ireland	Un proceso para la concentracion de un polipeptido.
NZ601790A (en) *	2010-02-24	2014-03-28	Zymenex As	Process for production and purification of recombinant lysosomal alpha-mannosidase
EP2588130B1 (en) *	2010-06-25	2016-08-17	Shire Human Genetic Therapies, Inc.	Cns delivery of therapeutic agents
AU2011270670B2 (en) *	2010-06-25	2017-01-12	Takeda Pharmaceutical Company Limited	Methods and compositions for CNS delivery of arylsulfatase A
CA2805413A1 (en)	2010-06-25	2011-12-29	Shire Human Genetic Therapies, Inc.	Methods and compositions for cns delivery of heparan n-sulfatase
ES2896060T3 (es)	2010-06-25	2022-02-23	Shire Human Genetic Therapies	Métodos y composiciones para la administración al SNC de arilsulfatasa A
EP2729566B1 (en)	2011-07-08	2017-03-15	Shire Human Genetic Therapies, Inc.	Methods for purification of arylsulfatase a
WO2013096899A2 (en)	2011-12-23	2013-06-27	Shire Human Genetic Therapies, Inc.	Stable formulations for cns delivery of arylsulfatase a
EA032680B1 (ru) *	2012-11-13	2019-07-31	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	ОЧИСТКА РЕКОМБИНАНТНОЙ ГАЛАКТОЦЕРЕБРОЗИД-БЕТА-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)
AU2013357812B2 (en) *	2012-12-11	2019-10-10	Centogene Gmbh	Method for the diagnosis of metachromatic leukodystrophy
EP2943568B1 (en)	2013-01-09	2019-11-20	Shire Human Genetic Therapies, Inc.	Methods for purification of arylsulfatase a
TWI828269B (zh)	2013-03-15	2024-01-01	美商百歐維拉提夫治療公司	因子ix多肽調配物
SG11201607642RA (en)	2014-03-24	2016-10-28	Biogen Ma Inc	Lyophilized factor ix formulations
US11584777B2 (en)	2017-08-31	2023-02-21	Green Cross Corporation	Method for purifying a sulfatase protein
KR102290596B1 (ko) *	2020-09-10	2021-08-19	주식회사 파이안바이오테크놀로지	분리된 미토콘드리아를 포함하는 주사용 조성물 및 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2041280A1 (en)	1990-05-10	1991-11-11	Yosuke Sawada	Arylsulfatase
NO960163D0 (no) *	1996-01-15	1996-01-15	Thomas Berg	Mutasjonsdeteksjon av bovin
ATE217799T1 (de)	1998-01-27	2002-06-15	Hemebiotech As	Behandlung von akuter intermittierender porphyria oder anderen porphyrischen krankheiten
IL140155A (en) *	1998-06-09	2005-12-18	Statens Seruminstitut	Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
JP4685238B2 (ja) *	1998-06-09	2011-05-18	ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト	静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
US6537777B1 (en)	1998-07-27	2003-03-25	Hemebiotech A/S	Human porphobilinogen deaminase sequences
AUPQ026799A0 (en) *	1999-05-10	1999-06-03	Csl Limited	Method of increasing protein stability by removing immunoglobulin aggregates
JP2003505057A (ja)	1999-07-27	2003-02-12	ヘム−バイオテックエイ／エス	ｒｈＰＢＧＤの製造及び急性間欠性ポルフィリン症（ＡＩＰ）及び他のポルフィリン症の患者を処置するための新規な治療方法
US6812339B1 (en) *	2000-09-08	2004-11-02	Applera Corporation	Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
AU2002232803A1 (en)	2000-11-15	2002-05-27	Genzyme Corporation	Expression system for recombinant proteins
WO2002098455A2 (en) *	2001-06-07	2002-12-12	Hemebiotech A/S	Production of recombinant human arylsulfatase a
WO2002099092A2 (en) *	2001-06-07	2002-12-12	Hemebiotech A/S	Production of recombinant human lysosomal alpha-mannosidase
WO2003002731A1 (en) *	2001-06-29	2003-01-09	Hemebiotech A/S	A PROCESS FOR PURIFICATION OF RECOMBINANT PORPHOBILINOGEN DEAMINASE (rhPBGD)
US7232670B2 (en) *	2001-09-28	2007-06-19	St. Jude Children's Research Hospital	Targeting proteins to cells expressing mannose receptors via expression in insect cells
ES2496493T3 (es)	2002-01-11	2014-09-19	Bioasis Technologies Inc.	Uso de p97 como sistema de administración de enzimas para la administración de enzimas lisosómicas terapéuticas
US7118675B2 (en) *	2002-02-04	2006-10-10	Millipore Corporation	Process for removing protein aggregates and virus from a protein solution
CH694697A5 (de)	2004-01-29	2005-06-15	Koelbl Engineering Und Consult	Gummimehl-enthaltende Elastomerlegierungen.
JP4586027B2 (ja) *	2004-01-30	2010-11-24	シャイアファーマシューティカルズアイルランドリミテッド	組換えアリールスルファターゼａの製造及び精製
WO2005094874A1 (en) *	2004-04-01	2005-10-13	Zymenex A/S	Medical use of alpha-mannosidase
US20060051347A1 (en) *	2004-09-09	2006-03-09	Winter Charles M	Process for concentration of antibodies and therapeutic products thereof
MX2008012748A (es) *	2006-04-04	2009-01-07	Shire Pharmaceuticals Ireland	Un proceso para la concentracion de un polipeptido.

2007
- 2007-04-04 MX MX2008012748A patent/MX2008012748A/es active IP Right Grant
- 2007-04-04 HU HUE13167427A patent/HUE042402T2/hu unknown
- 2007-04-04 NO NO20211305A patent/NO347673B1/no unknown
- 2007-04-04 CA CA2644642A patent/CA2644642C/en active Active
- 2007-04-04 NZ NZ588903A patent/NZ588903A/xx unknown
- 2007-04-04 EP EP13167428.5A patent/EP2631242B1/en active Active
- 2007-04-04 ES ES13167427T patent/ES2713488T3/es active Active
- 2007-04-04 PL PL08166902T patent/PL2100898T3/pl unknown
- 2007-04-04 KR KR1020147010563A patent/KR20140057678A/ko not_active Ceased
- 2007-04-04 NZ NZ571610A patent/NZ571610A/en unknown
- 2007-04-04 NZ NZ62312307A patent/NZ623123A/en unknown
- 2007-04-04 KR KR1020087026971A patent/KR101504969B1/ko active Active
- 2007-04-04 ES ES08166902T patent/ES2744499T3/es active Active
- 2007-04-04 NZ NZ582045A patent/NZ582045A/en unknown
- 2007-04-04 US US12/295,848 patent/US20090246187A1/en not_active Abandoned
- 2007-04-04 WO PCT/DK2007/000177 patent/WO2007112757A2/en not_active Ceased
- 2007-04-04 EP EP13167427.7A patent/EP2628746B1/en active Active
- 2007-04-04 SI SI200732097T patent/SI2628746T1/sl unknown
- 2007-04-04 CA CA2632528A patent/CA2632528C/en active Active
- 2007-04-04 AU AU2007234195A patent/AU2007234195B2/en active Active
- 2007-04-04 PT PT13167427T patent/PT2628746T/pt unknown
- 2007-04-04 NZ NZ597548A patent/NZ597548A/xx unknown
- 2007-04-04 KR KR1020157023398A patent/KR20150103339A/ko not_active Ceased
- 2007-04-04 CA CA2882501A patent/CA2882501C/en active Active
- 2007-04-04 NZ NZ607595A patent/NZ607595A/en unknown
- 2007-04-04 CN CN201510510807.4A patent/CN105233276A/zh active Pending
- 2007-04-04 NZ NZ568728A patent/NZ568728A/en unknown
- 2007-04-04 PL PL13167427T patent/PL2628746T3/pl unknown
- 2007-04-04 ES ES13167428T patent/ES2928096T3/es active Active
- 2007-04-04 JP JP2009503414A patent/JP2009532394A/ja active Pending
- 2007-04-04 EP EP08166902.0A patent/EP2100898B1/en active Active
- 2007-04-04 PL PL13167428.5T patent/PL2631242T3/pl unknown
- 2007-04-04 BR BRPI0709737-9A patent/BRPI0709737A2/pt not_active Application Discontinuation
- 2007-04-04 DK DK13167427.7T patent/DK2628746T3/en active
- 2007-04-04 EP EP07711305.8A patent/EP2004672B1/en active Active
2008
- 2008-05-30 NO NO20082510A patent/NO20082510L/no not_active Application Discontinuation
- 2008-06-19 ZA ZA2008/05346A patent/ZA200805346B/en unknown
- 2008-09-22 IL IL194267A patent/IL194267A/en active IP Right Grant
- 2008-09-26 AU AU2008229659A patent/AU2008229659B2/en active Active
- 2008-11-07 ZA ZA2008/09540A patent/ZA200809540B/en unknown
- 2008-11-12 NO NO20084776A patent/NO346368B1/no unknown
2009
- 2009-07-09 JP JP2009162789A patent/JP5384232B2/ja active Active
2011
- 2011-03-24 IL IL211905A patent/IL211905A0/en unknown
- 2011-04-26 US US13/094,321 patent/US8809055B2/en active Active
2013
- 2013-06-12 JP JP2013123735A patent/JP2013236633A/ja active Pending
- 2013-10-02 JP JP2013207365A patent/JP2014058521A/ja not_active Withdrawn
- 2013-10-02 JP JP2013207384A patent/JP5878152B2/ja active Active
2014
- 2014-07-01 US US14/321,642 patent/US20140314735A1/en not_active Abandoned
- 2014-11-30 IL IL235982A patent/IL235982A0/en unknown
2015
- 2015-09-16 IL IL241654A patent/IL241654B/en active IP Right Grant
- 2015-11-16 JP JP2015223865A patent/JP2016104000A/ja active Pending
2016
- 2016-02-11 US US15/041,841 patent/US9713634B2/en active Active
2017
- 2017-03-29 US US15/473,460 patent/US20170202927A1/en not_active Abandoned
- 2017-05-03 US US15/585,916 patent/US20180289777A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2882501C (en)	2021-09-07
ES2744499T3 (es)	2020-02-25
BRPI0709737A2 (pt)	2011-07-26
ES2928096T3 (es)	2022-11-15
IL235982A0 (en)	2015-01-29
NZ571610A (en)	2011-07-29
WO2007112757A3 (en)	2008-02-28
EP2628746B1 (en)	2019-01-09
HUE042402T2 (hu)	2019-06-28
NO20211305A1 (no)	2008-10-31
IL211905A0 (en)	2011-05-31
NO20084776L (no)	2008-10-31
EP2628746A3 (en)	2014-03-19
IL194267A0 (en)	2011-08-01
CA2632528C (en)	2022-07-12
NO347673B1 (no)	2024-02-19
NO346368B1 (no)	2022-06-27
IL241654A0 (en)	2015-11-30
JP5384232B2 (ja)	2014-01-08
EP2628746A2 (en)	2013-08-21
EP2631242A3 (en)	2013-10-02
IL194267A (en)	2015-10-29
AU2008229659B2 (en)	2013-01-31
NZ568728A (en)	2011-09-30
AU2007234195B2 (en)	2013-02-07
CA2882501A1 (en)	2007-10-11
US20180289777A1 (en)	2018-10-11
ZA200809540B (en)	2019-09-25
DK2628746T3 (en)	2019-04-01
JP5878152B2 (ja)	2016-03-08
JP2013236633A (ja)	2013-11-28
NZ597548A (en)	2013-08-30
JP2009532394A (ja)	2009-09-10
ZA200805346B (en)	2018-11-28
ES2713488T3 (es)	2019-05-22
KR20150103339A (ko)	2015-09-09
IL241654B (en)	2019-02-28
AU2007234195A1 (en)	2007-10-11
SI2628746T1 (sl)	2019-04-30
NZ607595A (en)	2014-10-31
JP2014058521A (ja)	2014-04-03
KR20140057678A (ko)	2014-05-13
US20160193304A1 (en)	2016-07-07
CA2632528A1 (en)	2007-10-11
NZ623123A (en)	2015-04-24
EP2100898B1 (en)	2019-06-19
EP2631242B1 (en)	2022-08-03
EP2100898A1 (en)	2009-09-16
CA2644642A1 (en)	2007-10-11
NO20082510L (no)	2008-10-31
US20120076767A1 (en)	2012-03-29
US20170202927A1 (en)	2017-07-20
AU2008229659A1 (en)	2008-10-23
JP2009273469A (ja)	2009-11-26
JP2016104000A (ja)	2016-06-09
CN105233276A (zh)	2016-01-13
US8809055B2 (en)	2014-08-19
WO2007112757A2 (en)	2007-10-11
KR101504969B1 (ko)	2015-03-24
US9713634B2 (en)	2017-07-25
MX2008012748A (es)	2009-01-07
CA2644642C (en)	2016-01-26
PL2628746T3 (pl)	2019-07-31
EP2631242A2 (en)	2013-08-28
EP2004672A2 (en)	2008-12-24
KR20090018894A (ko)	2009-02-24
PL2631242T3 (pl)	2023-03-20
US20140314735A1 (en)	2014-10-23
NZ588903A (en)	2012-08-31
US20090246187A1 (en)	2009-10-01
NZ582045A (en)	2011-07-29
PL2100898T3 (pl)	2019-11-29
JP2014051503A (ja)	2014-03-20
EP2004672B1 (en)	2015-08-19

Publication	Publication Date	Title
IL241654A0 (en)	2015-11-30	A process for concentrating a polypeptide
IL207429A0 (en)	2010-12-30	A method of purifying a peptide
PL2423315T3 (pl)	2015-06-30	Sposób osiągania lepszej ekspresji polipeptydu
AP2009004746A0 (en)	2009-02-28	Process for prepaiIrng diaminophenothiazinium compounds
IL197765A0 (en)	2009-12-24	Methods for purification of polypeptide conjugates
ZA200900836B (en)	2010-05-26	Process for the purification of FC-fusion proteins
EP2032031A4 (en)	2010-03-24	DETECTION OF ABNORMAL SUBSTANCE IN A KERATIN SAMPLE RECEIVED IN SUBJECTS WITH PATHOLOGY
GB0619941D0 (en)	2006-11-15	Chemical process
ZA200704159B (en)	2008-08-27	Method for analysis of pellet-cladding interaction
PT2079843T (pt)	2020-09-25	Processo para a produção de biogás
IL197979A0 (en)	2009-12-24	Method for peptide synthesis
EP2088136A4 (en)	2012-10-10	PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
GB0619942D0 (en)	2006-11-15	Chemical process
EP2006302A4 (en)	2011-02-16	PROTEIN COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
EP2045324A4 (en)	2010-07-21	METHODS FOR PRODUCING THE N36 BINDING PEPTIDE
GB201017990D0 (en)	2010-12-08	Chemical process
EP1968934A4 (en)	2014-02-26	METHOD FOR OBTAINING PURE OSELTAMIVIR
HK1120274A (en)	2009-03-27	A process for concentration of a polypeptide
GB2440637B (en)	2011-04-13	Method of facilitating analysis of a peptide
GB2471803B (en)	2011-02-16	Chemical process
IL181944A0 (en)	2007-07-04	A process for the concentration of hcl
GB201017988D0 (en)	2010-12-08	Chemical process
GB0618832D0 (en)	2006-11-01	Chemical process
GB0805124D0 (en)	2008-04-23	Process for modifying proteins
IL193470A0 (en)	2009-05-04	Process for preparing of 2-alkyl-3-aryl-prop-2- ene-1-ols